Xeris pharmaceuticals inc.

Major-Pharmaceuticals

XERS


180 North LaSalle Street
Chicago , IL 60601

Executive/
Director

Price

  • Last Close
  • $ 3.62
    $ +0.82 29.29 %
    Dec 9, 2024
  • 52-Week High/Low
  • $3.22 - $1.47
  • YTD
  • 54%

  • Trading Volume
  • 22,732
  • Market Cap Full
  • $ 500M
  • Shares Outstanding
  • 138.1M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - -40.9% -5% -8.3% -12.6% 22.6% -6%
Q2 - - - -6.1% 14.5% 4% -9.8% -39.8% 60.7% -2.3%
Q3 - - - -2.4% -17.3% 8% -39.8% 1.3% -29% -
Q4 - - - -1.9% -27% -16.9% 19.6% -14.7% 34.3% -
J F M A M J J A S O N D
2024 4.7% 25% -28.1% -5.4% - - - - - - - -
2023 -6.8% 11.3% 18.1% 38.7% 13.3% 2.3% -0.4% -13% -18.1% -1.6% 1.6% 26.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%-58%-32%-40%-55%77%54%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - -5.49 -1.07 -0.89 -0.3 - -0.12
Q2 - - - -3.07 -1.28 -0.63 -0.41 - -0.14
Q3 - - - -0.71 -1.22 -0.35 - - -0.09
Q4 - - - - -1.24 -0.27 -1.55 -0.10 -
A 0 0 0 -9.3 -4.8 -2.14 -1.6 -0.7 -0.35

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 135.5 137.3
Jun - 135.5 137.3
Sep - 136 -
Dec 124.7 136 138.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.9 0.7 1.1 1 -
Fixed Asset Turnover 10 6.3 2.9 0.1 1
Total Asset Turnover 0.3 0.2 0.1 - -
Leverage
Debt Ratio 1 0.6 0.6 0.7 0.3
Debt – Equity Ratio 4.2 0.9 2.6 4.1 0.4
Interest Coverage -6.3 -14.4 -12 -30.5 -59
Equity multiplier 0.2 0.1 0.2 1.5 -